{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:41:49Z","timestamp":1761561709034},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Faculty of Medicine (CUHK)","award":["2041448"],"award-info":[{"award-number":["2041448"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Peptides"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1016\/j.peptides.2012.12.019","type":"journal-article","created":{"date-parts":[[2012,12,27]],"date-time":"2012-12-27T19:15:17Z","timestamp":1356635717000},"page":"13-21","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Reversal of ABCG2-mediated multidrug resistance by human cathelicidin and its analogs in cancer cells"],"prefix":"10.1016","volume":"40","author":[{"given":"Kenneth K.W.","family":"To","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.X.","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.C.M.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chi Hin","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.peptides.2012.12.019_bib0005","first-page":"417","article-title":"Potent and specific inhibition of the breast cancer resistance protein multidrug transporter in vitro and in mouse intestine by a novel analogue of fumitremorgin C","volume":"1","author":"Allen","year":"2002","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.peptides.2012.12.019_bib0010","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/S0076-6879(98)92039-0","article-title":"Drug-stimulated ATPase activity in crude membranes of human MDR1-transfected mammalian cells","volume":"292","author":"Ambudkar","year":"1998","journal-title":"Methods Enzymol"},{"key":"10.1016\/j.peptides.2012.12.019_bib0015","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1517\/17425250903228834","article-title":"ABCG2: the key to chemoresistance in cancer stem cells?","volume":"5","author":"An","year":"2009","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.peptides.2012.12.019_bib0020","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/sj.bjp.0706904","article-title":"Multiple drug binding sites on the R482G isoform of the ABCG2 transporter","volume":"149","author":"Clark","year":"2006","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.peptides.2012.12.019_bib0025","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1517\/13543784.2012.679339","article-title":"Investigational ABC transporter inhibitors","volume":"21","author":"Falasca","year":"2012","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.peptides.2012.12.019_bib0030","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1208\/s12248-009-9132-1","article-title":"Structure\u2013activity relationships and quantitative structure\u2013activity relationships for breast cancer resistance protein (ABCG2)","volume":"11","author":"Gandhi","year":"2009","journal-title":"AAPS J"},{"key":"10.1016\/j.peptides.2012.12.019_bib0035","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1124\/dmd.108.022046","article-title":"Substrate-dependent breast cancer resistance protein (Bcrp1\/Abcg2)-mediated interactions: consideration of multiple binding sites in in vitro assay design","volume":"37","author":"Giri","year":"2009","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.peptides.2012.12.019_bib0040","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1124\/dmd.106.014605","article-title":"ABCG2 (breast cancer resistance protein\/mitoxantrone resistance-associated protein) ATPase assay: a useful tool to detect drug-transporter interactions","volume":"35","author":"Glavinas","year":"2007","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.peptides.2012.12.019_bib0045","first-page":"151","article-title":"In vitro characterization of the anticancer activity of membrane-active cationic peptides. I. Peptide-mediated cytotoxicity and peptide-enhanced cytotoxic activity of doxorubicin against wild-type and p-glycoprotein over-expressing tumor cell lines","volume":"15","author":"Johnstone","year":"2000","journal-title":"Anticancer Drug Des"},{"key":"10.1016\/j.peptides.2012.12.019_bib0050","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1002\/ijc.2910490512","article-title":"P-glycoprotein expression and schedule dependence of adriamycin cytotoxicity in human colon carcinoma cell lines","volume":"49","author":"Lai","year":"1991","journal-title":"Int J Cancer"},{"key":"10.1016\/j.peptides.2012.12.019_bib0055","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1634\/theoncologist.8-5-411","article-title":"The role of ABC transporters in clinical practice","volume":"8","author":"Leonard","year":"2003","journal-title":"Oncologist"},{"key":"10.1016\/j.peptides.2012.12.019_bib0060","doi-asserted-by":"crossref","first-page":"5776","DOI":"10.1021\/ja0584875","article-title":"Solution structures of human LL-37 fragments and NMR-based identification of a minimal membrane-targeting antimicrobial and anticancer region","volume":"128","author":"Li","year":"2006","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.peptides.2012.12.019_bib0065","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ijpharm.2011.12.046","article-title":"Reversal of P-glycoprotein-mediated multidrug resistance by a synthetic \u03b1-aminoxy peptidomimetic","volume":"424","author":"Ma","year":"2012","journal-title":"Int J Pharm"},{"key":"10.1016\/j.peptides.2012.12.019_bib0070","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.2174\/138161210790963823","article-title":"Antimicrobial peptides present in mammalian skin and gut are multifunctional defence molecules","volume":"16","author":"Metz-Boutigue","year":"2010","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.peptides.2012.12.019_bib0075","doi-asserted-by":"crossref","first-page":"7981","DOI":"10.1158\/0008-5472.CAN-10-0111","article-title":"Apatinib (YN968D1) reverses multidrug resistance by inhibiting the efflux function of multiple ATP-binding cassette transporters","volume":"70","author":"Mi","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.peptides.2012.12.019_bib0080","doi-asserted-by":"crossref","first-page":"4219","DOI":"10.1074\/jbc.M411338200","article-title":"Function-dependent conformational changes of the ABCG2 multidrug transporter modify its interaction with a monoclonal antibody on the cell surface","volume":"280","author":"Ozvegy-Laczka","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.peptides.2012.12.019_bib0085","doi-asserted-by":"crossref","first-page":"e5676","DOI":"10.1371\/journal.pone.0005676","article-title":"A novel two mode-acting inhibitor of ABCG2-mediated multidrug transport and resistance in cancer chemotherapy","volume":"4","author":"Peng","year":"2009","journal-title":"PLoS ONE"},{"key":"10.1016\/j.peptides.2012.12.019_bib0090","doi-asserted-by":"crossref","first-page":"8224","DOI":"10.1016\/j.bmc.2008.07.034","article-title":"Structure\u2013activity relationships of new inhibitors of breast cancer resistance protein (ABCG2)","volume":"16","author":"Pick","year":"2008","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.peptides.2012.12.019_bib0095","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1158\/1078-0432.CCR-04-0212","article-title":"Breast cancer resistance protein in drug resistance of primitive CD34+38-cells in acute myeloid leukemia","volume":"11","author":"Raaijmakers","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.peptides.2012.12.019_bib0100","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1189\/jlb.68.6.785","article-title":"Leukocyte antimicrobial peptides: multifunctional effector molecules of innate immunity","volume":"68","author":"Risso","year":"2000","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.peptides.2012.12.019_bib0105","first-page":"145","article-title":"Overexpression of the ATP-binding cassette half-transporter, ABCG2 (Mxr\/BCRP\/ABCP1), in flavopiridol-resistant human breast cancer cells","volume":"7","author":"Robey","year":"2001","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.peptides.2012.12.019_bib0110","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s10555-007-9042-6","article-title":"ABCG2: determining its relevance in clinical drug resistance","volume":"26","author":"Robey","year":"2007","journal-title":"Cancer Metastasis Rev"},{"key":"10.1016\/j.peptides.2012.12.019_bib0115","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1158\/0008-5472.CAN-03-3298","article-title":"Pheophorbide A is a specific probe for ABCG2 function and inhibition","volume":"64","author":"Robey","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.peptides.2012.12.019_bib0120","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1152\/physrev.00037.2005","article-title":"Human multidrug resistance ABCB and ABCG transporters: participation in a chemoimmunity defense system","volume":"86","author":"Sarkadi","year":"2006","journal-title":"Physiol Rev"},{"key":"10.1016\/j.peptides.2012.12.019_bib0125","first-page":"152","article-title":"Multidrug resistance-associated protein gene overexpression and reduced drug senstivity of topoisomerase II in a human breast carcinoma MCF7 cell line selected for etoposide resistance","volume":"54","author":"Schneider","year":"1994","journal-title":"Cancer Res"},{"key":"10.1016\/j.peptides.2012.12.019_bib0130","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/ijc.11528","article-title":"Reversal of breast cancer resistance protein (BCRP\/ABCG2)-mediated drug resistance by novobiocin, a coumermycin antibiotic","volume":"108","author":"Shiozawa","year":"2004","journal-title":"Int J Cancer"},{"key":"10.1016\/j.peptides.2012.12.019_bib0135","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1093\/jnci\/82.13.1107","article-title":"New colorimetric cytotoxicity assay for anticancer-drug screening","volume":"82","author":"Skehan","year":"1990","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.peptides.2012.12.019_bib0140","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ejps.2011.10.021","article-title":"Antibody binding shift assay for rapid screening of drug interactions with the human ABCG2 multidrug transporter","volume":"45","author":"Telbisz","year":"2012","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.peptides.2012.12.019_bib0145","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1158\/1541-7786.MCR-10-0270","article-title":"Upregulation of ABCG2 by romidepsin via the aryl hydrocarbon receptor pathway","volume":"9","author":"To","year":"2011","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.peptides.2012.12.019_bib0150","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.addr.2008.08.007","article-title":"Physiological and pharmacological roles of ABCG2 (BCRP): recent findings in Abcg2 knockout mice","volume":"61","author":"Vlaming","year":"2009","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.peptides.2012.12.019_bib0155","doi-asserted-by":"crossref","first-page":"27841","DOI":"10.1074\/jbc.C700133200","article-title":"Intramolecular disulphide bond is a critical check point determining degradative fates of ATP-binding cassette (ABC) transporter ABCG2 protein","volume":"282","author":"Wakabayashi","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.peptides.2012.12.019_bib0160","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.peptides.2011.04.017","article-title":"Effects of cathelicidin and its fragments on three key enzymes of HIV-1","volume":"32","author":"Wong","year":"2011","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2012.12.019_bib0165","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1111\/j.1440-1746.2012.07158.x","article-title":"Protective effects of cathelicidin-encoding Lactococcus lactis in murine ulcerative colitis","volume":"27","author":"Wong","year":"2012","journal-title":"J Gastroent Hepat"},{"key":"10.1016\/j.peptides.2012.12.019_bib0170","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2174\/1874467210801020093","article-title":"Reversal of ABC drug transporter-mediated multidrug resistance in cancer cells: evaluation of current strategies","volume":"1","author":"Wu","year":"2008","journal-title":"Curr Mol Pharmacol"},{"key":"10.1016\/j.peptides.2012.12.019_bib0175","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1002\/jcp.22026","article-title":"The host defense peptide LL-37 activates the tumor-suppressing bone morphogenetic protein signaling via inhibition of proteasome in gastric cancer cells","volume":"223","author":"Wu","year":"2010","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.peptides.2012.12.019_bib0180","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1002\/ijc.25489","article-title":"Emerging roles of the host defense peptide LL-37 in human cancer and its potential therapeutic applications","volume":"27","author":"Wu","year":"2010","journal-title":"Int J Cancer"},{"key":"10.1016\/j.peptides.2012.12.019_bib0185","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1124\/jpet.106.102467","article-title":"The cationic host defense peptide rCRAMP promotes gastric ulcer healing in rats","volume":"318","author":"Yang","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.peptides.2012.12.019_bib0190","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1096\/fj.06-6075com","article-title":"Kallikrein-mediated proteolysis regulates the antimicrobial effects of cathelicidins in skin","volume":"20","author":"Yamasaki","year":"2006","journal-title":"FASEB J"}],"container-title":["Peptides"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978112005037?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978112005037?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,4]],"date-time":"2024-05-04T01:52:57Z","timestamp":1714787577000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0196978112005037"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":38,"alternative-id":["S0196978112005037"],"URL":"https:\/\/doi.org\/10.1016\/j.peptides.2012.12.019","relation":{},"ISSN":["0196-9781"],"issn-type":[{"value":"0196-9781","type":"print"}],"subject":[],"published":{"date-parts":[[2013,2]]}}}